Dissecting the restricted mean time in favor of treatment.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of biopharmaceutical statistics"
DOI: 10.1080/10543406.2023.2210658
Abstract: The restricted mean time in favor (RMT-IF) summarizes the treatment effect on a hierarchical composite endpoint with mortality at the top. Its crude decomposition into "stage-wise effects," i.e., the net average time gained by the… read more here.
Keywords: time favor; time; restricted mean; treatment ... See more keywords